Overview

Paracetamol CSF Pharmacokinetics Study

Status:
Completed
Trial end date:
2011-11-01
Target enrollment:
Participant gender:
Summary
Despite its use for decades all over the world, the exact mechanism of action of paracetamol is not fully understood and essentially involves a combination of hypotheses. It is known to have an effect via the central nervous system, and of the many mechanisms proposed, one hypothesis is that it may have indirectly activate CB1 (cannabinoid) receptors, through its novel metabolite AM404. This study aims to elucidate cerebrospinal levels of paracetamol and to measure the concentration of its metabolites, including AM404 in CSF. This may, in turn, give us useful information on the mechanism of action of paracetamol.
Phase:
Phase 4
Details
Lead Sponsor:
Barts & The London NHS Trust
Treatments:
Acetaminophen